Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The C-terminal region of mucin 1 (MUC1-C) is a transmembrane subunit that plays a crucial role in oncogenesis by modulating intracellular signaling pathways. It is overexpressed in many carcinomas and contributes to epithelial-mesenchymal transition, cancer stem cell phenotype, and immune evasion. Its stable membrane association post-cleavage makes it an attractive target for antibody-based therapies.
Monoclonal antibodies targeting MUC1-C epitopes to induce cell death or modulate signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucin 1 Cell Surface Associated C-Terminal (MUC1-C).